Aclaris Therapeutics Inc - Kortsiktig aksjeanalyse - Analyse | GetAGraph.com
Kort siktMellomlang siktLang siktSignaler

Aclaris Therapeutics Inc [ACRS]

Børs: NASDAQ
Sektor: Healthcare
Bransje: Biotechnology
Sist oppdatert 22 Jun 2026 @ 08:13 (Exchange is closed)
Siste: $0 0.00%
-0.41 (↓)
GaG Algo Score™
v1.0
Kort
-0.41 (↓)
Medium
0.74 (↓)
Lang
1.25 (↓)

Statistikk

Dagens volum 0
Gjennomsnittlig volum 0
Markedsverdi 542.68M
EPS $-0.150 (Q1 | 2026-05-07)
Neste resultatdato ($-0.160) 2026-08-06
ATR14 $0.244 (5.42%)
Mulig dagsving $4.38 - $4.62 (5.57%)

Støtte- og motstandsnivåer

Linje

Pivotdata

Pivotstatistikk
Måltall Snitt Median Std.avvik
Gevinst % 9.14% 9.14% 0.87%
Tap % -12.95% -12.95% 0.00%
Varighet 5.7d 6d 2.5d
Totalt antall pivoter 4
Gevinst-/tapsbein 3 (2 Gevinst / 1 Tap)
Siste pivot Top @ $4.50 den 2026-06-18
Endring siden siste pivot $0.00 (0.00%)
Neste pivotprognose Siste: $0.00
Forventet neste type Bottom
Forventet pris (snitt) $3.92
Forventet pris (median) $3.92
Forventet prisintervall (~68%) $3.92 - $3.92
Endring til snittmål $3.92 (N/A)
Forventet dato (snitt) 2026-06-23
Forventet datointervall (~68%) 2026-06-21 - 2026-06-26
Grunnlag Based on 1 historical losses (Avg: -12.95%, Median: -12.95%, StdDev of Abs: 0.00%) and duration (Avg: 5.7 days, StdDev: 2.5 days)
Merk Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Moderate gain for Aclaris Therapeutics Incon Thursday .

Aclaris Therapeutics Inc (ACRS) stock price experienced a significant rise on Thursday after the stock rose $0.0800 (1.81%) from the previous session on extraordinarily high volume. The stock moved in line with the rising NASDAQ that gained 1.91%. With 4.32M shares traded, volume yesterday reached $19.45M. This was 3.14M shares more than the prior day. Compared to the 10-day average of 1.16M shares, volume was more than the average.

Aclaris Therapeutics Inc signals

There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (3.3%), medium- (3.3%), and long-term (3.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Aclaris Therapeutics Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $4.53. approximately $0.0300 (0.67%) away. Pushing up towards resistance. Breaking above this level could signal further upside where next resistance level will be found at $4.55. On a fall back there will be support at $4.43 The dis das resistance s14.43 -

Aclaris Therapeutics Inc Evaluation

  • Kort score: -0.41
  • Medium score: 0.74
  • Lang score: 1.25